Skip to main content
. 2013 Feb 7;12:16. doi: 10.1186/1475-2859-12-16

Figure 2.

Figure 2

The testing of the prepared gfpIB-fetuin (A) and gfpIB-asialofetuin (B) conjugates by the evaluation of their impact on the extent of the positive hemagglutination zone. Hemagglutination-inhibition assay was designed as for optimization (Figure 1). 1 control (sabIBs with RBC, no conjugate), 2–6 – interaction of sabIBs with conjugates and RBC; concentration of gfpIB-fetuin and gfpIB-asialofetuin conjugates is 1.5-fold increasing from 2 to 6.